Net Income

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

The body contouring firm faces investor unease over a delayed annual report, even as it points to a sales rebound from a new marketing push.

Amid a tough property market, Beike's $300M dividend and massive buybacks highlight its financial strength and a commitment to rewarding investors.

As it heads to the ROTH Conference, fledgling solar firm TOYO showcases its aggressive vertical integration strategy to attract key institutional investment.

Amid a strategic overhaul, Koppers Holdings aims to woo investors with a story of improved profitability and its essential role in global infrastructure.

The broker eliminates overnight fees globally, promising no hidden costs. But does this move truly redefine trading or is it a strategic market play?

VNET smashes 2025 revenue goals on AI demand, but a net loss and huge capex plan raise questions about its high-stakes growth strategy in China.

A new report projects explosive growth for Europe's solid-state battery sector, as automakers race to adopt safer, high-energy tech despite major hurdles.

Pilgrim’s 'Nani Ka Secret' campaign, with Rashmika Mandanna, blends tradition and K-beauty science, fueling its rapid rise in India's beauty market.

Despite a revenue dip, Kelyniam Global slashed its net loss, secured FDA clearance for a breakthrough implant, and rejected a buyout, charting its own course.

Domestic Metals completes a key survey at its Smart Creek project, setting the stage for a Q2 drill campaign amid a booming metals market.

Silvercrest Asset Management will report its 2025 results on March 17, with investors watching if record AUM growth can overcome rising costs and margin pressure.

34 new ASEAN and ASIA records were set in a landmark event, but the launch of a new Food Records initiative to boost tourism and preserve culture stole the show.

The Southern Michigan bank's dividend hike and capital strategy highlight its financial health and commitment to shareholders amid a dynamic regional economy.

After a failed reverse stock split, shipping firm OceanPal faces delisting. Can its ambitious AI subsidiary, SovereignAI, save it from the exchange?

A battle for Carver Bancorp's future erupts as its board rejects a turnaround expert, sparking a fierce fight with its largest shareholder.

Actelion Pharmaceuticals settles a class action lawsuit for $65M, accused of illegally blocking a cheaper generic for its life-saving hypertension drug.

OTC-listed ProText Mobility unveils an audacious plan to tokenize biotech assets, partner with major banks, and uplist to a major exchange. Can it deliver?

Facing a staggering $546M loss and a 'Selective Default' rating, specialty materials firm Trinseo shutters plants while betting on a green tech pivot.

The firm is set to unveil new tech bridging traditional radio with broadband, tackling one of public safety's biggest interoperability challenges.